Stay updated on ABNCoV2 Vaccine in Previous SARS-CoV-2 Vaccinated Adults Clinical Trial

Sign up to get notified when there's something new on the ABNCoV2 Vaccine in Previous SARS-CoV-2 Vaccinated Adults Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ABNCoV2 Vaccine in Previous SARS-CoV-2 Vaccinated Adults Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    No Change Detected
  4. Check
    3 days ago
    No Change Detected
  5. Check
    4 days ago
    No Change Detected
  6. Check
    6 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage, indicating a shift in the dosage comparison between ABNCoV2 and Comirnaty vaccines in a Phase 3 trial for adult subjects previously vaccinated for SARS-CoV-2.
    Difference
    0.1%
    Check dated 2024-06-06T14:32:25.000Z thumbnail image
  7. Check
    21 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for study participants, specifying requirements such as age, vaccination history, and health conditions. Previously, this section only indicated that no information was provided.
    Difference
    34%
    Check dated 2024-05-22T21:19:26.000Z thumbnail image
  8. Check
    43 days ago
    Change Detected
    Difference
    0.8%
    Check dated 2024-04-30T22:22:08.000Z thumbnail image

Stay in the know with updates to ABNCoV2 Vaccine in Previous SARS-CoV-2 Vaccinated Adults Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ABNCoV2 Vaccine in Previous SARS-CoV-2 Vaccinated Adults Clinical Trial page.